Globant (NYSE:GLOB) Azioni

Globant

Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.

Globant SA

GLOBAL BLOCKCHAIN ACQUISITION CORP RT PUR 1/10 COM

GLOBAL BRANDS GROUP NEW by Global Brands Group Holding Ltd.

GLOBAL CONNECTION PCL by GLOBAL CONNECTION PUBLIC CO LTD.

GLOBAL DEFENSE & NATL SEC SYS INC COM

GLOBAL DINING INC ORD by Global Dining, Inc.

GLOBAL GAS CORP DEL COM

GLOBAL HUNTER CORP NEW by Global Hunter Corp.

GLOBAL INTL CR GROUP LTD by GLOBAL INTL CR GROUP LTD

GLOBAL INVTS LTD by GLOBAL INVTS LTD.

GLOBAL IT HLDGS INC by Global IT Holdings, Inc.

GLOBAL LIGHTS ACQUISITION CORP RT

GLOBAL PARTNER ACQUISITION CORP II UNIT 1 ORD SHSS CL A & 1/3 WT EXP

GLOBAL PVQ SE UNSP/ADR by Global PVQ SE

GLOBAL STAR ACQUISITION INC RT

GLOBAL SWEETENERS HLDGS by Global Sweeteners Holdings Ltd.

GLOBAL TECHS GROUP INC by Global Technologies Group, Inc.

GLOBAL WHOLEHEALTH PTNRS by Global Wholehealth Partners Corporation

GLOBALFOUNDRIES Inc

GLOBALINK INVT INC RT

Global AI Inc

GLOBAL ARENA HLDG INC by Global Arena Holding, Inc.

Global Arena Holding Inc

GLOBAL ATOMIC CORP by Global Atomic Corp.

Global Atomic Corp

GLOBAL BATTERY METALS LTD by Global Battery Metals Ltd.

Global Battery Metals Ltd

GLOBAL BIO CHEM TCH U/ADR by Global BioChem Technology Group Co., Ltd.

Global Bio-chem Technology Group Co Ltd

GLOBAL BIO CHEM TECH GP by Global BioChem Technology Group Co., Ltd.

Global Blockchain Acquisition Corp Warrants (01/01/9999)

Global Blockchain Acquisition Corp

Global Blockchain Acquisition Corp Ordinary Shares - Class A

Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share

Global Blue Group Holding AG

Global Blue Group Holding AG Ordinary Shares

GLOBAL BROKERAGE INC A by Global Brokerage, Inc.

Global Brokerage Inc

Global Business Travel Group, Inc. Class A Common Stock

Global Business Travel Group Inc

GLOBAL CLEAN ENGY HLDGS by Global Clean Energy Holdings, Inc.

Global Clean Energy Holdings Inc

GLOBAL CLEAN ENERGY INC by Global Clean Energy, Inc.

Global Clean Energy Inc

Global Coin Research

GLOBAL COMPLIANCE APP CRP by GLOBAL COMPLIANCE APPLICATIONS CORP.

Global Compliance Applications Corp

GLOBAL COPPER CORP by GLOBAL COPPER CORP.

Global Copper Corp

GLOBAL CORD BLOOD CORP by Global Cord Blood Corporation

Global Cord Blood Corp

GLOBAL CRSSIG ARLINS NEW by Global Crossing Airlines Group Inc.

Global Crossing Airlines Group Inc

GLOBAL CROSSING AIR B by Global Crossing Airlines Group Inc.

Global Cryptocurrency

GLOBAL DEV&ENVIR RES INC by Global Development & Environmental Resources, Inc.

Global Development & Environmental Resources Inc

GLOBAL DIAMOND EXCH INC by Global Diamond Exchange, Inc.

Global Diamond Exchange Inc

GLOBAL DIGITAL SLTNS INC by Global Digital Solutions, Inc.

Global Digital Solutions Inc

Global Diversified Marketing Group Inc

GLOBAL DOMINION ACCESS SA by Global Dominion Access SA

Global Dominion Access SA

Global E Online Ltd

GLOBAL ECOLOGY CORP by Global Ecology Corp.

Global Ecology Corp

GLOBAL ED CMNTYS CORP by Global Education Communities Corp.

Global Education Communities Corp

GLOBAL ENERGY METALS CORP by Global Energy Metals Corp.

Global Energy Metals Corp

GLOBAL ENERGY NETWORK by Global Energy Networks Corp.

Global Energy Networks Corp

Global Engine Group Holding Limited - Class A Ordinary Shares

Global Engine Group Holding Ltd

GLOBAL ENTMT HOLDINGS INC by Global Entertainment Holdings, Inc.

Global Entertainment Holdings Inc

GLOBAL ENVIRNMNTL ENGY CP by Global Environmental Energy Corp.

Global Environmental Energy Corp

GLOBAL FASHION GROUP by GLOBAL FASHION GROUP SA

Global Fashion Group SA

GLOBAL FERRONICKEL by Global Ferronickel Holdings Inc.

Global Ferronickel Holdings Inc

Global Food and Ingredients Inc

GLOBAL GAMING TECHS by Global Gaming Technologies Corp.

Global Gaming Technologies Corp

Global Gas Corp

GLOBAL GAS CORPORATION A by Global Gas Corporation

Global Gold Corp

GLOBAL HEALTH CLINICS LTD by Global Health Clinics Ltd.

Global Health Clinics Ltd

Global Helium Corp

Global Hemp Group Inc

GLOBAL HEMP GROUP INC by Global Hemp Group Inc

Global Indemnity Group, LLC Class A Common Stock (DE)

Global Indemnity Group LLC

Global Industrial Co

Global Infrastructure Active ETF

GLOBAL INNOVATIVE PLATFOM by Global Innovative Platforms Inc.

Global Innovative Platforms Inc

Global Interactive Technologies Inc

Global Interactive Technologies, Inc. Common Stock - Common Stock

GLOBAL LEADERS CORP by GLOBAL LEADERS CORP

Global Leaders Corp

GLOBAL LI-ION GRAPH ORD by Global Li-Ion Graphite Corp

Global Li-Ion Graphite Corp

Global Lights Acquisition Corp

GLOBAL LIGHTS ACQ CORP by Global Lights Acquisition Corp.

Global Lights Acquisition Corp Units

Global Links Corp

GLOBAL LITHIUM RES LTD by GLOBAL LITHIUM RES LTD

Global Lithium Resources Ltd

GLOBAL MED PRODS HDGS INC by Global Medical Products Holdings, Inc.

Global Medical Product Holdings Inc

Global Medical REIT Inc. Series A Cumulative Redeemable Preferred Stock

Global Medical REIT Inc

Global Mofy AI Limited - Class A Ordinary Shares

Global Mofy AI Ltd

Global Net Lease Inc

Global Net Lease, Inc. 7.25% Series A Cumulative Redeemable Preferred Stock, $0.01 par value per share

Global Net Lease, Inc. 6.875% Series B Cumulative Redeemable Perpetual Preferred Stock

Global Net Lease, Inc. 7.50% Series D Cumulative Redeemable Perpetual Preferred Stock

Global Net Lease, Inc. 7.375% Series E Cumulative Redeemable Perpetual Preferred Stock

Global Oil & Gas Ltd

GLOBAL ONE RE INVT CP by Global One Real Estate Investment Corp.

Global One Real Estate Investment Corp

Global PVQ SE

Global Partners LP Common Units representing Limited Partner Interests

Global Partners LP

Global Partners LP 9.50% Series B Fixed Rate Cumulative Redeemable Perpetual Preferred Units representing limited partner interests

GLOBAL PAYMENT TECHS INC by Global Payment Technologies, Inc.

Global Payment Technologies Inc

Global Payments Inc

GLOBAL PHARMATECH INC by Global Pharmatech, Inc.

Global Pharmatech Inc

Global Pole Trusion Group Corp

Globant S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) reported worse-than-expected first-quarter financial results, issued second-quarter guidance below estimates, and cut its FY25 guidance, after the closing <a href="https://www.benzinga.com/quote/GLOB/earnings">bell on Thursday</a>.
Globant reported quarterly earnings of $1.50 per share which missed the analyst consensus estimate of $1.58 per share. The company reported quarterly sales of $611.09 million which missed the analyst consensus estimate of $621.38 million.
&#8220;Globant&#8217;s spirit of building and reinvention is stronger than ever. We are largely focused on AI-related opportunities, and assisting our clients in transforming their respective businesses and leveraging technology to drive growth and competitive advantages. Our comprehensive growth strategy unites our 100-squared client-centric vision with our industry-specialized AI Studios and subscription model. This strategy is powered by our AI Pods and the Globant Enterprise AI platform, which we believe positions Globant as the only player in the industry with such a comprehensive offering. With a robust pipeline and expected sequential growth for Q2, we are not just navigating the future; as builders, we are actively creating it, reaffirming our commitment to lead the next wave of technological transformation,&#8221; said Martín Migoya, Globant&#8217;s CEO and co-founder.
Globant shares gained 3.1% to trade at $104.67 on Monday.
These analysts made changes to their price targets on Globant following earnings announcement.
<ul class="wp-block-list">
<li>Goldman Sachs analyst James Schneider maintained Globant with a Neutral and lowered the price target from $225 to $120.</li>
<li>Mizuho analyst Dan Dolev maintained the stock with an Outperform rating and lowered the price target from $194 to $153.</li>
</ul>
Considering buying GLOB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="562" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19134451/image-232-1024x562.png" alt="" class="wp-image-920178" style="width:628px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19134451/image-232-1024x562.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19134451/image-232-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19134451/image-232-768x422.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19134451/image-232.png 1102w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45490061/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-6">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

Earnings

News

Price Target

Analyst Ratings

Trading Ideas

GLOB

Globant Analysts Slash Their Forecasts After Q1 Results

Mizuho analyst Dan Dolev maintains Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) with a Outperform and lowers the price target from $194 to $153.

Mizuho Maintains Outperform on Globant, Lowers Price Target to $153

Goldman Sachs analyst James Schneider maintains Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) with a Neutral and lowers the price target from $225 to $120.

Goldman Sachs Maintains Neutral on Globant, Lowers Price Target to $120

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Friday.
The Dow traded up 0.59% to 42,570.89 while the NASDAQ rose 0.37% to 19,183.25. The S&amp;P 500 also rose, gaining, 0.54% to 5,948.96.
Check This Out: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45464436/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-4">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Health care shares jumped by 0.8% on Friday.
In trading on Wednesday, energy stocks fell by 0.8%.
Top Headline
Flowers Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLO#NYSE">FLO</a>) reported weaker-than-expected earnings for the first quarter on Friday.
The company posted quarterly earnings of 35 cents per share which missed the analyst consensus estimate of 38 cents per share. The company reported quarterly sales of $1.55 billion which missed the analyst consensus estimate of $1.60 billion.
FLowers Foods lowered its FY2025 adjusted EPS guidance from $1.18-$1.28 to $1.05-$1.15 and lowered FY2025 sales guidance, excluding the Simple Mills acquisition, from $5.18 billion-$5.26 billion to $5.08 billion-$5.17 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) shares shot up 35% to $12.48 after the company reported better-than-expected quarterly EPS results.</li>
<li>Shares of Inozyme Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INZY#NASDAQ">INZY</a>) got a boost, surging 177% to $3.9450 after the company announced BioMarin will acquire the company for about $270 million.</li>
<li>TSS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) shares were also up, gaining 81% to $16.05 after the company reported a year-over-year increase in first-quarter revenue results.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Globant S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) shares dropped 28% to $95.27 after the company reported worse-than-expected first-quarter financial results, issued second-quarter guidance below estimates, and cut its FY25 guidance.</li>
<li>Shares of Doximity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) were down 14% to $50.04 after the company issued FY26 sales guidance below estimates.</li>
<li>Zenvia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENV#NASDAQ">ZENV</a>) was down, falling 34% to $1.20 following full year 2024 results.</li>
</ul>
Commodities In commodity news, oil traded up 0.6% to $62.01 while gold traded down 1.2% at $3,188.60.
Silver traded down 1.5% to $32.190 on Friday, while copper fell 2.2% to $4.5795.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.14%, while Spain's IBEX 35 Index rose 0.61%. London's FTSE 100 gained 0.46%, Germany's DAX 40 fell 0.01% and France's CAC 40 gained 0.14% during the session.
Asia Pacific Markets
Asian markets closed lower on Friday, with Japan's Nikkei falling 0.005%, Hong Kong's Hang Seng Index declining 0.46%, China's Shanghai Composite Index falling 0.40% and India's BSE Sensex declining 0.24%.
Economics
<ul class="wp-block-list">
<li>The University of Michigan consumer sentiment for the US dipped to 50.8 in May compared to April's reading of 52.2 and down from market estimates of 53.4.</li>
<li>U.S. import prices rose by 0.1% month-over-month in April compared to a revised 0.4% decline in the previous month.</li>
<li>U.S. building permits declined by 4.7% to an annualized rate of 1.412 million in April, recording the lowest level in eleven months.</li>
<li>U.S. housing starts increased 1.6% month-over-month in April to an annual rate of 1.361 million.</li>
<li>U.S. export prices increased 0.1% month-over-month in April, versus market estimates of a 0.5% fall.</li>
</ul>
Now Read This:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/markets/25/05/45466164/jim-cramer-prefers-autozone-over-rival-buy-the-one-thats-not-going-to-stock-split">Jim Cramer Prefers AutoZone Over Rival: &#8216;Buy The One That&#8217;s Not Going To Stock Split&#8217;</a> </li>
</ul>
Photo via Shutterstock

Equities

Eurozone

Commodities

Markets

DOCS

INZY

QUBT

TSSI

ZENV

Gold Down Over 1%; Flowers Foods Posts Weak Earnings

<h3>Gainers</h3>
<ul>
<li>TSS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) stock rose 76.1% to $15.62 during Friday's regular session. The market value of their outstanding shares is at $351.0 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) stock moved upwards by 32.57% to $12.25. The market value of their outstanding shares is at $1.6 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) stock moved upwards by 30.75% to $1.4. The market value of their outstanding shares is at $97.0 million. </li>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) stock increased by 28.12% to $2.46. The company's market cap stands at $4.3 million. As per the press release, Q2 earnings came out yesterday. </li>
<li>Evolv Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLV#NASDAQ">EVLV</a>) shares increased by 26.19% to $5.3. The market value of their outstanding shares is at $866.3 million. </li>
<li>CoreWeave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) shares rose 23.43% to $81.18. The market value of their outstanding shares is at $37.7 billion. As per the press release, Q1 earnings came out 2 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Zenvia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENV#NASDAQ">ZENV</a>) stock declined by 27.6% to $1.34 during Friday's regular session. The market value of their outstanding shares is at $69.5 million. </li>
<li>Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) shares fell 25.1% to $99.5. The market value of their outstanding shares is at $4.3 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>ReAlpha Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) stock decreased by 19.72% to $0.56. The market value of their outstanding shares is at $25.8 million. As per the press release, Q1 earnings came out today. </li>
<li>WidePoint (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/WYY#AMEX">WYY</a>) stock fell 19.25% to $4.28. The company's market cap stands at $41.8 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Next Technology Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) stock declined by 18.71% to $2.06. The company's market cap stands at $14.4 million. </li>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares declined by 15.6% to $1.51. The market value of their outstanding shares is at $15.1 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AIRE

CETX

CRWV

EVLV

GRYP

MLGO

Next Technology Holding Inc. - Ordinary Shares

NXTT

12 Information Technology Stocks Moving In Friday's Intraday Session

Wall Street fought for a fifth consecutive day of gains on Friday, with major indexes edging slightly higher by midday in New York as investors continued to digest the week's significant trade breakthroughs and <a href="https://www.benzinga.com/news/econ-s">recalibrate their economic expectations.</a>
The S&amp;P 500 rose 0.1% to 5,925, its highest level since early March, while the Nasdaq 100 held firm after a strong prior session. Gains were broad but cautious as markets balanced optimism over de-escalating tariffs with growing macro concerns. 
Healthcare stocks rebounded from recent underperformance, buoyed by a rally in Eli Lilly &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), while the energy sector lagged as crude prices cooled.
The U.S. dollar surged after the <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45470155/consumer-sentiment-crashes-to-5-year-lows-as-inflation-fears-reach-1981-levels">University of Michigan's consumer sentiment report</a> delivered one of the bleakest stagflationary signals in recent decades. 
The headline Consumer Sentiment Index dropped to its lowest level since June 2020, while the Consumer Expectations subindex hit levels not seen since 1980. Year-ahead inflation expectations soared to 7.3%, the highest since late 1981. 
The spike in inflation fears rattled rate-cut bets. Fed funds futures slashed the odds of a June interest rate cut to just 5%, effectively pricing out any move next month. 
Markets now fully price the first rate cut only by October 2025, with a second possibly arriving in December.
Treasury yields rose as bond prices fell, with the 30-year yield rising back to 4.90%, following the dismal sentiment data. The combination of rising yields and a stronger dollar weighed heavily on gold, which dropped 1.8% and is headed for its worst weekly performance since November 2024. 
In crypto, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) bounced back and reclaimed the $104,500 level. 
<h3 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,103.26</td>
<td>0.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,932.74</td>
<td>0.3%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,424.05</td>
<td>0.2%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,350.21</td>
<td>0.1%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:15 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched 0.2% up to $591.88.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.2% to $424.32.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;edged 0.1% up $520.03.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 0.4% to $209.16.</li>
<li>The&nbsp;Health Care&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) outperformed, up 1%; the&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 0.5%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
<ul class="wp-block-list">
<li>Applied Materials inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) fell 6.1% following a miss in revenue forecasts and revised guidance amid trade challenges with China. </li>
<li>Take-Two Interactive Software inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) fell 2% after missing earnings expectations last quarter. </li>
</ul>
Read now: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/large-cap/25/05/45472025/loebs-third-point-exits-meta-tesla-rotates-into-staples-telecom-industrials">Loeb&#8217;s Third Point Exits Meta, Tesla, Rotates Into Staples, Telecom, Industrials </a></li>
</ul>
Photo: Shutterstock

Large Cap

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

ETFs

$BTC

AMAT

SPDR Dow Jones Industrial Average ETF Trust

TTWO

Select Sector SPDR-Consumer Discretionary

Stocks Fight For Fifth Day Of Gains, Dollar Rebounds As Inflation Fears Go Haywire: What's Driving Markets Friday?

Piper Sandler analyst Arvind Ramnani downgrades Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) from Overweight to Neutral and lowers the price target from $154 to $116.

Downgrades

Piper Sandler Downgrades Globant to Neutral, Lowers Price Target to $116

Guggenheim analyst Jonathan Lee maintains Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) with a Buy and lowers the price target from $150 to $125.

Guggenheim Maintains Buy on Globant, Lowers Price Target to $125

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.
Shares of Globant S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected first-quarter financial results, issued second-quarter guidance below estimates, and <a href="https://www.benzinga.com/quote/GLOB">cut its FY25 guidance</a>.
Globant reported quarterly earnings of $1.50 per share which missed the analyst consensus estimate of $1.58 per share. The company reported quarterly sales of $611.09 million which missed the analyst consensus estimate of $621.38 million.
Globant shares dipped 26.2% to $98.00 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Doximity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) dipped 22.1% to $45.52 in pre-market trading after the company issued FY26 sales guidance below estimates.</li>
<li>Travere Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>) declined 15.2% to $17.94 in pre-market trading. The company announced that the FDA accepted its supplemental New Drug Application for traditional approval of FILSPARI for the treatment of focal segmental glomerulosclerosis.</li>
<li>Arrive AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAI#NASDAQ">ARAI</a>) fell 13.2% to $11.50 in pre-market trading after dipping 67% on Thursday.</li>
<li>BRF S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRFS#NYSE">BRFS</a>) dropped 11.1% to $3.19 in pre-market trading after gaining 3% on Thursday.</li>
<li>Lithium Americas Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAC#NYSE">LAC</a>) dipped 10.8% to $2.82 in pre-market trading as the company filed for mixed shelf of up to $1.0 billion.</li>
<li>KULR Technology Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NASDAQ">KULR</a>) fell 10.1% to $1.33 in pre-market trading after the company reported first-quarter financial results and missed its EPS and revenue estimates.</li>
<li>Applied Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) fell 5.8% to $164.65 in pre-market trading. Applied Materials reported better-than-expected earnings for its second quarter, while sales missed estimates. Applied Materials said it expects third-quarter revenue of $7.2 billion, plus or minus $500 million, versus estimates of $7.19 billion. The company expects third-quarter adjusted earnings to be between $2.15 and $2.55 per share, versus estimates of $2.32 per share.</li>
<li>Take-Two Interactive Software, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) fell 3.7% to $223.68 in pre-market trading. Take-Two reported fourth-quarter net bookings of $1.58 billion, up 17% year-over-year. The total beat a Street consensus estimate of $1.55 billion according to data from Benzinga Pro. The company said it expects first quarter net bookings to be in a range of $1.25 billion to $1.30 billion. The company guides for full fiscal-year net bookings to be in a range of $5.90 billion to $6.00 billion.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

ARAI

BRFS

KULR

TVTX

Globant, Doximity, Applied Materials And Other Big Stocks Moving Lower In Friday's Pre-Market Session

12 analysts have shared their evaluations of Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Globant and provided 12-month price targets. The average target is $185.92, accompanied by a high estimate of $242.00 and a low estimate of $115.00. A decline of 14.91% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1747400428_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Globant among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$115.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Divya Goyal</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$140.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$160.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Arvind Ramnani</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$154.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$225.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$220.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Leonardo Olmos</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$217.00</td>
</tr>
<tr>
<td>Divya Goyal</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$170.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$165.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Tien-Tsin Huang</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$242.00</td>
<td>$248.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$220.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Arvind Ramnani</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$230.00</td>
<td>$237.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Globant. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Globant compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Globant's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Globant's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/GLOB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Globant analyst ratings.</a>
<h2>Delving into Globant's Background</h2>
Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.
<h3>A Deep Dive into Globant's Financials</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Positive Revenue Trend: Examining Globant's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 10.64% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Globant's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.64% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Globant's ROE excels beyond industry benchmarks, reaching 1.88%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Globant's ROA stands out, surpassing industry averages. With an impressive ROA of 1.19%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.21.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Globant

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO